RxDoctor Payments Data

David Dickerson, MD

Pain Medicine · Evanston, ILNPI 1548581226

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Abbott at 48.7% of the total. 2025 is the largest year on record at $142,191, 6.1 times the $23,137 reported in 2019. Among pain medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$557,948in general payments, 2019–2025

Across 1,121 payments — averaging $497.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$271K
  • SPR Therapeutics, Inc$88K
  • Vertos Medical, Inc.$77K
  • Stryker$63K
  • Biotronik NRO, Inc.$28K
  • Pfizer$6K
  • plus $23K from 21 others
$207,776in research payments, 2019–2025

Across 64 payments — averaging $3246.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$117K
  • SPR Therapeutics, Inc$91K

What the payments were for

  • Consulting fees$264,87947%
  • Speaking & faculty fees$182,84233%
  • Travel & lodging$60,53611%
  • Food & beverage$49,6719%
  • Education$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$557,948 in reported general payments places this provider in the 95th percentile of 233 pain medicine providers in Illinois.

See all pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$189,706
Medicare patients
502
Services billed
1,685

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen347$5,379
Celecoxib74$4,335
Gabapentin104$1,711
Topiramate64$1,214
Chlorzoxazone11$593
Pregabalin27$442
Duloxetine Hcl51$438
Amitriptyline Hcl21$361
Hydroxyzine Hcl17$253
Naltrexone Hcl11$177
Nortriptyline Hcl22$169
Tramadol Hcl21$157
Meloxicam14$97
Tizanidine Hcl11$72
Trazodone Hcl11$9

Paid to pharmacies, not to this prescriber.

Other pain medicine in Evanston

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →